title: CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope.
abstract: Cytotoxic CD8+ T cells (CTLs) play a critical role in controlling viral infections. HIV-infected individuals develop CTL responses against epitopes derived from viral proteins, but also against cryptic epitopes encoded by viral alternative reading frames (ARF). We studied here the mechanisms of HIV-1 escape from CTLs targeting one such cryptic epitope, Q9VF, encoded by an HIVgag ARF and presented by HLA-B*07. Using PBMCs of HIV-infected patients, we first cloned and sequenced proviral DNA encoding for Q9VF. We identified several polymorphisms with a minority of proviruses encoding at position 5 an aspartic acid (Q9VF/5D) and a majority encoding an asparagine (Q9VF/5N). We compared the prevalence of each variant in PBMCs of HLA-B*07+ and HLA-B*07- patients. Proviruses encoding Q9VF/5D were significantly less represented in HLA-B*07+ than in HLA-B*07- patients, suggesting that Q9FV/5D encoding viruses might be under selective pressure in HLA-B*07+ individuals. We thus analyzed ex vivo CTL responses directed against Q9VF/5D and Q9VF/5N. Around 16% of HLA-B*07+ patients exhibited CTL responses targeting Q9VF epitopes. The frequency and the magnitude of CTL responses induced with Q9VF/5D or Q9VF/5N peptides were almost equal indicating a possible cross-reactivity of the same CTLs on the two peptides. We then dissected the cellular mechanisms involved in the presentation of Q9VF variants. As expected, cells infected with HIV strains encoding for Q9VF/5D were recognized by Q9VF/5D-specific CTLs. In contrast, Q9VF/5N-encoding strains were neither recognized by Q9VF/5N- nor by Q9VF/5D-specific CTLs. Using in vitro proteasomal digestions and MS/MS analysis, we demonstrate that the 5N variation introduces a strong proteasomal cleavage site within the epitope, leading to a dramatic reduction of Q9VF epitope production. Our results strongly suggest that HIV-1 escapes CTL surveillance by introducing mutations leading to HIV ARF-epitope destruction by proteasomes.
authors: INSERM, UMR-S945, Université Pierre et Marie Curie (UPMC), Paris, France. sylvain.cardinaud@upmc.fr
authors: Sylvain
authors: S
authors: Cardinaud
authors: Gesa
authors: G
authors: Consiglieri
authors: Romain
authors: R
authors: Bouziat
authors: Alejandra
authors: A
authors: Urrutia
authors: Stéphanie
authors: S
authors: Graff-Dubois
authors: Slim
authors: S
authors: Fourati
authors: Isabelle
authors: I
authors: Malet
authors: Julien
authors: J
authors: Guergnon
authors: Amélie
authors: A
authors: Guihot
authors: Christine
authors: C
authors: Katlama
authors: Brigitte
authors: B
authors: Autran
authors: Peter
authors: P
authors: van Endert
authors: François A
authors: FA
authors: Lemonnier
authors: Victor
authors: V
authors: Appay
authors: Olivier
authors: O
authors: Schwartz
authors: Peter M
authors: PM
authors: Kloetzel
authors: Arnaud
authors: A
authors: Moris
references: Nature. 2009 Apr 2;458(7238):641-5
references: 19242411
references: J Virol. 2009 Feb;83(4):1845-55
references: 19036810
references: J Infect Dis. 2005 Jun 15;191(12):2053-63
references: 15897991
references: Eur J Immunol. 2002 May;32(5):1368-75
references: 11981824
references: J Virol. 2009 Feb;83(3):1228-39
references: 19019964
references: J Exp Med. 2008 Oct 27;205(11):2673-82
references: 18936238
references: Int Immunol. 2003 Jun;15(6):765-72
references: 12750360
references: Nature. 2000 Apr 13;404(6779):770-4
references: 10783891
references: J Exp Med. 1999 Nov 1;190(9):1227-40
references: 10544195
references: J Virol. 1994 Jul;68(7):4650-5
references: 8207839
references: Tissue Antigens. 1995 Nov;46(5):355-67
references: 8838344
references: J Clin Invest. 2007 Nov;117(11):3563-75
references: 17975674
references: J Exp Med. 2004 Apr 5;199(7):905-15
references: 15067030
references: J Exp Med. 1996 Oct 1;184(4):1319-29
references: 8879204
references: J Exp Med. 1996 Mar 1;183(3):1131-40
references: 8642255
references: J Exp Med. 2010 Jan 18;207(1):39-49
references: 20038599
references: J Virol. 2005 Nov;79(21):13239-49
references: 16227247
references: Nat Immunol. 2001 Jul;2(7):644-51
references: 11429550
references: J Virol. 2004 Feb;78(3):1324-32
references: 14722287
references: J Immunol. 1998 Jan 1;160(1):39-50
references: 9551954
references: J Exp Med. 2007 Oct 29;204(11):2505-12
references: 17954573
references: PLoS One. 2009 Aug 19;4(8):e6687
references: 19690614
references: Nature. 2004 Dec 9;432(7018):769-75
references: 15592417
references: AIDS. 2009 Sep 24;23(15):1945-54
references: 19644347
references: Blood. 2004 Apr 1;103(7):2648-54
references: 14576049
references: J Exp Med. 2004 Apr 19;199(8):1053-63
references: 15078897
references: J Immunol. 2010 Jan 1;184(1):67-72
references: 19949108
references: EMBO J. 2001 May 15;20(10):2357-66
references: 11350924
references: Nat Med. 2007 Jan;13(1):46-53
references: 17173051
references: J Immunol. 2004 Sep 15;173(6):3925-34
references: 15356141
references: Clin Vaccine Immunol. 2009 Sep;16(9):1369-71
references: 19571107
references: J Biol Chem. 2001 Sep 28;276(39):36474-81
references: 11479311
references: J Exp Med. 2009 Jun 8;206(6):1253-72
references: 19487423
references: J Exp Med. 2001 Jul 2;194(1):1-12
references: 11435468
references: J Virol. 2010 Jun;84(11):5508-19
references: 20335254
references: J Acquir Immune Defic Syndr. 2010 Jan;53(1):36-46
references: 19910798
references: Clin Chim Acta. 2006 Jan;363(1-2):71-82
references: 16102740
references: Immunogenetics. 1999 Nov;50(3-4):213-9
references: 10602881
references: J Exp Med. 1995 Dec 1;182(6):1883-95
references: 7500034
references: Nature. 1991 Dec 12;354(6353):453-9
references: 1721107
references: Nature. 1991 May 23;351(6324):290-6
references: 1709722
references: Science. 2003 Sep 5;301(5638):1367-71
references: 12958358
references: Nat Chem Biol. 2010 Aug;6(8):572-80
references: 20644544
references: Nat Med. 1997 Feb;3(2):212-7
references: 9018241
references: Nat Rev Immunol. 2004 Aug;4(8):630-40
references: 15286729
references: Nat Rev Mol Cell Biol. 2001 Mar;2(3):179-87
references: 11265247
references: J Exp Med. 2007 Oct 1;204(10):2473-85
references: 17893201
references: J Exp Med. 2010 Jan 18;207(1):61-75
references: 20065065
references: J Immunol. 2004 Sep 15;173(6):3838-43
references: 15356131
references: Nature. 2001 Jul 19;412(6844):334-8
references: 11460164
references: J Immunol. 2005 Oct 1;175(7):4618-26
references: 16177107
references: J Virol. 2007 Feb;81(4):2031-8
references: 17108020
references: Nat Immunol. 2009 Jun;10(6):636-46
references: 19412183
references: Immunity. 1996 Aug;5(2):115-24
references: 8769475
references: J Exp Med. 2002 Feb 4;195(3):353-8
references: 11828010
references: J Immunol. 2006 Dec 15;177(12):8283-9
references: 17142722
references: PLoS One. 2010 Jan 21;5(1):e8692
references: 20098683
references: Blood. 2006 Sep 1;108(5):1643-51
references: 16675708
references: Nature. 2009 Aug 6;460(7256):711-6
references: 19661910
references: Nat Med. 1997 Feb;3(2):205-11
references: 9018240
references: J Exp Med. 2010 Jan 18;207(1):51-9
references: 20065064
references: J Immunol. 2006 Jan 15;176(2):1053-61
references: 16393993